Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Special Report
  • Published:

Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT

Bone Marrow Transplantation volume 35, pages 737–746 (2005)Cite this article

Summary:

Over the last 25 years, the numbers of hematopoietic stem cell transplant (SCT) patients have increased rapidly. Infections have been major obstacles for successful transplantation. Thus, infection prevention is very important in transplant recipients. As the results of transplantation have improved, the number of long-term survivors has increased. Vaccination is a potentially important strategy for reducing the risk for vaccine-preventable infections after SCT. The EBMT produced recommendations for vaccination of SCT recipients published in Bone Marrow Transplantation in 1995. This paper updates the previous recommendations based on current knowledge.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. CDC. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. MMWR Morb Mortal Wkly Rep 2000; 49 (RR-10): 1–125.

  2. Ljungman P, Lewensohn-Fuchs I, Hammarstrom V et al. Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation. Blood 1994; 84: 657–663.

    CAS  PubMed  Google Scholar 

  3. Ljungman P, Aschan J, Barkholt L et al. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease. Bone Marrow Transplant 2004; 34: 589–593.

    Article  CAS  PubMed  Google Scholar 

  4. Engelhard D, Nagler A, Hardan I et al. Antibody response to a two-dose regimen of influenza vaccine in allogeneic T cell-depleted and autologous BMT recipients. Bone Marrow Transplant 1993; 11: 1–5.

    CAS  PubMed  Google Scholar 

  5. Guinan EC, Molrine DC, Antin JH et al. Polysaccharide conjugate vaccine responses in bone marrow transplant patients. Transplantation 1994; 57: 677–684.

    Article  CAS  PubMed  Google Scholar 

  6. Ljungman P, Duraj V, Magnius L . Response to immunization against polio after allogeneic marrow transplantation. Bone Marrow Transplant 1991; 7: 89–93.

    CAS  PubMed  Google Scholar 

  7. Pauksen K, Hammarström V, Ljungman P et al. Immunity to poliovirus and immunization with inactivated poliovaccine after autologous bone marrow transplantation. Clin Infect Dis 1994; 18: 547–552.

    Article  CAS  PubMed  Google Scholar 

  8. Pauksen K, Linde A, Hammarstrom V et al. Granulocyte–macrophage colony-stimulating factor as immunomodulating factor together with influenza vaccination in stem cell transplant patients. Clin Infect Dis 2000; 30: 342–348.

    Article  CAS  PubMed  Google Scholar 

  9. Gandhi MK, Egner W, Sizer L et al. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Bone Marrow Transplant 2001; 28: 775–781.

    Article  CAS  PubMed  Google Scholar 

  10. Engelhard D, Handsher R, Naparstek E et al. Immune responses to polio vaccination in bone marrow transplant recipients. Bone Marrow Transplant 1991; 8: 295–300.

    CAS  PubMed  Google Scholar 

  11. Storek J, Dawson MA, Lim LC et al. Efficacy of donor vaccination before hematopoietic cell transplantation and recipient vaccination both before and early after transplantation. Bone Marrow Transplant 2004; 33: 337–346.

    Article  CAS  PubMed  Google Scholar 

  12. Molrine D, Guinan E, Antin J et al. Donor immunization with Haemophilus influenzae type B (HIB)-conjugate vaccine in allogeneic bone marrow transplantation. Blood 1996; 87: 3012–3018.

    CAS  PubMed  Google Scholar 

  13. Molrine DC, Antin JH, Guinan EC et al. Donor immunization with pneumococcal conjugate vaccine and early protective antibody responses following allogeneic hematopoietic cell transplantation. Blood 2003; 101: 831–836.

    Article  CAS  PubMed  Google Scholar 

  14. Ilan Y, Nagler A, Adler R et al. Adoptive transfer of immunity to hepatitis B virus after T cell-depleted allogeneic bone marrow transplantation. Hepatology 1993; 18: 246–252.

    CAS  PubMed  Google Scholar 

  15. Parkkali T, Stenvik M, Ruutu T et al. Randomized comparison of early and late vaccination with inactivated poliovirus vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 20: 663–668.

    Article  CAS  PubMed  Google Scholar 

  16. Engelhard D, Cordonnier C, Shaw PJ et al. Early and late invasive pneumococcal infection following stem cell transplantation: a European Bone Marrow Transplantation survey. Br J Haematol 2002; 117: 444–450.

    Article  PubMed  Google Scholar 

  17. Parkkali T, Kayhty H, Ruutu T et al. A comparison of early and late vaccination with Haemophilus influenzae type B conjugate and pneumococcal polysaccaride vaccines after allogeneic BMT. Bone Marrow Transplant 1996; 18: 961–967.

    CAS  PubMed  Google Scholar 

  18. Avanzini M, Carra A, Macccario R et al. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 1995; 15: 137–144.

    Article  CAS  PubMed  Google Scholar 

  19. Barra A, Cordonnier C, Preziosi MP et al. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients. J Infect Dis 1992; 166: 1021–1028.

    Article  CAS  PubMed  Google Scholar 

  20. Hammarström V, Pauksen K, Azinge J et al. The influence of graft versus host reaction on the response to pneumococcal vaccination in bone marrow transplant patients. J Supportive Care Cancer 1993; 1: 195–199.

    Article  Google Scholar 

  21. Lortan J, Vellodi A, Jurges E, Hugh-Jones K . Class- and subclass-specific pneumococcal antibody levels and response to immunization after bone marrow transplantation. Clin Exp Immunol 1992; 88: 512–519.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Spoulou V, Victoratos P, Ioannidis JP, Grafakos S . Kinetics of antibody concentration and avidity for the assessment of immune response to pneumococcal vaccine among children with bone marrow transplants. J Infect Dis 2000; 182: 965–969.

    Article  CAS  PubMed  Google Scholar 

  23. Parkkali T, Kayhty H, Anttila M et al. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines. Bone Marrow Transplant 1999; 24: 671–678.

    Article  CAS  PubMed  Google Scholar 

  24. Nordoy T, Husebekk A, Aaberge IS et al. Humoral immunity to viral and bacterial antigens in lymphoma patients 4–10 years after high-dose therapy with ABMT. Serological responses to revaccinations according to EBMT guidelines. Bone Marrow Transplant 2001; 28: 681–687.

    Article  CAS  PubMed  Google Scholar 

  25. Molrine D, Guinan E, Antin J et al. Haemophilus influenzae type b (HIB)-conjugate immunization before bone marrow harvest in autologous bone marrow transplantation. Bone Marrow Transplant 1996; 17: 1149–1155.

    CAS  PubMed  Google Scholar 

  26. Kroon FP, van Dissel JT, Ravensbergen E et al. Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults. Vaccine 2000; 19: 886–894.

    Article  CAS  PubMed  Google Scholar 

  27. Vernacchio L, Neufeld EJ, MacDonald K et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease. J Pediatr 1998; 133: 275–278.

    Article  CAS  PubMed  Google Scholar 

  28. Avanzini MA, Carra AM, Maccario R et al. Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls. J Clin Immunol 1998; 18: 193–201.

    Article  CAS  PubMed  Google Scholar 

  29. Parkkali T, Kayhty H, Lehtonen H et al. Tetravalent meningococcal polysaccharide vaccine is immunogenic in adult allogeneic BMT recipients. Bone Marrow Transplant 2001; 27: 79–84.

    Article  CAS  PubMed  Google Scholar 

  30. Ljungman P, Wiklund HM, Duraj V et al. Response to tetanus toxoid immunization after allogeneic bone marrow transplantation. J Infect Dis 1990; 162: 496–500.

    Article  CAS  PubMed  Google Scholar 

  31. Hammarström V, Pauksen K, Björkstrand B et al. Tetanus immunity in autologus bone marrow and blood stem cell transplant patients. Bone Marrow Transplantation 1998; 22: 67–72.

    Article  PubMed  Google Scholar 

  32. Parkkali T, Ölander R-M, Ruutu T et al. A randomized comparison between early and late vaccination with tetanus toxoid vaccine after allogeneic BMT. Bone Marrow Transplant 1997; 19: 933–938.

    Article  CAS  PubMed  Google Scholar 

  33. de la Camara R, Martino R, Granados E et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transplant 2000; 26: 291–298.

    Article  CAS  PubMed  Google Scholar 

  34. Aschan J, Ringdén O, Ljungman P et al. Influenza B in transplant patients. Scand J Infect Dis 1989; 21: 349–350.

    Article  CAS  PubMed  Google Scholar 

  35. Ljungman P, Andersson J, Aschan J et al. Influenza A in immunocompromised patients. Clin Infect Dis 1993; 17: 244–247.

    Article  CAS  PubMed  Google Scholar 

  36. Ljungman P, Ward KN, Crooks BN et al. Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 2001; 28: 479–484.

    Article  CAS  PubMed  Google Scholar 

  37. Whimbey E, Elting LS, Couch RB et al. Influenza A virus infections among hospitalized adult bone marrow transplant recipients. Bone Marrow Transplant 1994; 13: 437–440.

    CAS  PubMed  Google Scholar 

  38. Zuckerman M, Brink N, Kyi M, Tedder R . Exposure of immunocompromised individuals to health-care workers immunized with oral poliovaccine. The Lancet 1994; 343: 985–986.

    Article  CAS  Google Scholar 

  39. Locasciulli A, Alberti A, Bandini G et al. Allogeneic bone marrow transplantation from HBsAg+ donors: a multicenter study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Blood 1995; 86: 3236–3240.

    CAS  PubMed  Google Scholar 

  40. Wimperis J, Brenner M, Prentice H et al. Transfer of a functioning humoral immune system in transplantation of T-lymphocyte-depleted bone marrow. Lancet 1986; 1: 339–343.

    Article  CAS  PubMed  Google Scholar 

  41. Ilan Y, Nagler A, Zeira E et al. Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipients. Bone Marrow Transplant 2000; 26: 633–638.

    Article  CAS  PubMed  Google Scholar 

  42. Dhedin N, Douvin C, Kuentz M et al. Reverse seroconversion of hepatitis B after allogeneic bone marrow transplantation: a retrospective study of 37 patients with pretransplant anti-HBs and anti-HBc. Transplantation 1998; 66: 616–619.

    Article  CAS  PubMed  Google Scholar 

  43. Nakano T, Shimono Y, Sugiyama K et al. Clinical features of measles in immunocompromised children. Acta Paediatr Jpn 1996; 38: 212–217.

    Article  CAS  PubMed  Google Scholar 

  44. Kaplan L, Daum R, Smaron M, McCarthy C . Severe measles in immunocompromised patients. JAMA 1992; 267: 1237–1241.

    Article  CAS  PubMed  Google Scholar 

  45. Machado CM, Goncalves FB, Pannuti CS et al. Measles in bone marrow transplant recipients during an outbreak in Sao Paulo, Brazil. Blood 2002; 99: 83–87.

    Article  CAS  PubMed  Google Scholar 

  46. Pauksen K, Duraj V, Ljungman P et al. Immunity to and immunization against measles, rubella and mumps in patients after autologous bone marrow transplantation. Bone Marrow Transplant 1992; 9: 427–432.

    CAS  PubMed  Google Scholar 

  47. Ljungman P, Fridell E, Lönnqvist B et al. Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine. J Infect Dis 1989; 159: 610–615.

    Article  CAS  PubMed  Google Scholar 

  48. King SM, Saunders EF, Petric M, Gold R . Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients. Bone Marrow Transplant 1996; 17: 633–636.

    CAS  PubMed  Google Scholar 

  49. Spoulou V, Giannaki M, Vounatsou M et al. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants. Bone Marrow Transplant 2004; 33: 1187–1190.

    Article  CAS  PubMed  Google Scholar 

  50. Sauerbrei A, Prager J, Hengst U et al. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 1997; 20: 381–383.

    Article  CAS  PubMed  Google Scholar 

  51. Hata A, Asanuma H, Rinki M et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 2002; 347: 26–34.

    Article  PubMed  Google Scholar 

  52. Rio B, Marjanovic Z, Lévy V et al. Vaccination for yellow fever after bone marrow transplantation. Bone Marrow Transplant 1996; 17 (Suppl. 1): 95.

    Google Scholar 

Download references

Acknowledgements

This work was supported by the European Leukemia Net and the EBMT.

Author information

Authors and Affiliations

  1. Department of Hematology, Karolinska University Hospital/Huddinge, Stockholm, Sweden

    P Ljungman, D Engelhard, R de la Cámara, H Einsele, A Locasciulli, R Martino, P Ribaud, K Ward & C Cordonnier

Authors
  1. P Ljungman
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D Engelhard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R de la Cámara
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Einsele
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Locasciulli
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R Martino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. P Ribaud
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. K Ward
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. C Cordonnier
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

for the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Corresponding author

Correspondence to P Ljungman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ljungman, P., Engelhard, D., de la Cámara, R. et al. Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT. Bone Marrow Transplant 35, 737–746 (2005). https://doi.org/10.1038/sj.bmt.1704870

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1704870

Keywords

This article is cited by

Search

Advanced search

Quick links